Lifevantage (LFVN) Expected to Announce Earnings on Wednesday

Lifevantage (NASDAQ:LFVN) will likely be releasing its Q4 2025 results before the market opens on Wednesday, August 27th. Analysts expect Lifevantage to post earnings of $0.17 per share and revenue of $57.9310 million for the quarter. Interested persons may visit the the company’s upcoming Q4 2025 earningresults page for the latest details on the call scheduled for Thursday, August 28, 2025 at 4:00 PM ET.

Lifevantage Trading Down 4.4%

Shares of LFVN stock opened at $13.09 on Wednesday. Lifevantage has a 1 year low of $7.09 and a 1 year high of $27.38. The firm’s fifty day moving average price is $13.02 and its two-hundred day moving average price is $14.26. The firm has a market capitalization of $164.80 million, a P/E ratio of 18.97 and a beta of 0.45.

Insider Activity at Lifevantage

In other news, CFO Carl Aure sold 2,746 shares of Lifevantage stock in a transaction dated Tuesday, July 1st. The shares were sold at an average price of $13.39, for a total value of $36,768.94. Following the completion of the transaction, the chief financial officer owned 133,303 shares of the company’s stock, valued at $1,784,927.17. This trade represents a 2.02% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 20.65% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Wasatch Advisors LP lifted its stake in shares of Lifevantage by 6.6% during the 2nd quarter. Wasatch Advisors LP now owns 446,341 shares of the company’s stock worth $5,838,000 after buying an additional 27,765 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Lifevantage by 106.1% during the 2nd quarter. Geode Capital Management LLC now owns 245,332 shares of the company’s stock worth $3,210,000 after buying an additional 126,274 shares during the last quarter. Squarepoint Ops LLC lifted its stake in shares of Lifevantage by 68.1% during the 2nd quarter. Squarepoint Ops LLC now owns 70,507 shares of the company’s stock worth $922,000 after buying an additional 28,574 shares during the last quarter. Man Group plc lifted its stake in shares of Lifevantage by 72.5% during the 2nd quarter. Man Group plc now owns 53,098 shares of the company’s stock worth $695,000 after buying an additional 22,319 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership acquired a new stake in shares of Lifevantage during the 2nd quarter worth about $597,000. Institutional investors own 35.32% of the company’s stock.

Lifevantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.